Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic tacrolimus dosing after living-donor kidney transplantation
2010-018917-30Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Feb 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in kidney failure and Renal Insufficiency (RI) (2 arms), sponsored by Erasmus MC. Started Feb 2010; status: active.
02
Drugs
tacrolimus
03
Conditions
kidney failureRenal Insufficiency (RI)
Beyond the preview
Go deeper on 2010-018917-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018917-30.